OBJECTIVE AND DESIGN: HIV-1 is known to adapt to the human immune system, leading to accumulation of escape mutations during the course of infection within an individual. Cross-sectional studies have shown an inverse correlation between the prevalence of human leukocyte antigen (HLA) alleles in a population and the number of cytotoxic T lymphocyte (CTL) escape mutations in epitopes restricted by those HLA alleles. Recently, it was demonstrated that at a population level HIV-1 is adapting to the humoral immune response, which is reflected in an increase in resistance to neutralizing antibodies over time. Here we investigated whether adaptations to cellular immunity have also accumulated during the epidemic. METHODS: We compared the number of CTL epitopes in HIV-1 strains isolated from individuals who seroconverted at the beginning of the HIV-1 epidemic and from individuals who seroconverted in recent calendar time. RESULTS: The number of CTL epitopes in HIV-1 variants restricted by the most common HLA alleles in the population did not change significantly during the epidemic. In contrast, we found a significant loss of CTL epitopes restricted by HLA-B alleles associated with a low relative hazard of HIV-1 disease progression during the epidemic. Such a loss was not observed for CTL epitopes restricted by HLA-A alleles. CONCLUSION: Despite the large degree of HLA polymorphism, HIV-1 has accumulated adaptations to CTL responses within 20 years of the epidemic. The fact that such adaptations are driven by the HLA-B molecules that provide best protection against HIV-1 disease progression has important implications for our understanding of HIV evolution.
OBJECTIVE AND DESIGN:HIV-1 is known to adapt to the human immune system, leading to accumulation of escape mutations during the course of infection within an individual. Cross-sectional studies have shown an inverse correlation between the prevalence of human leukocyte antigen (HLA) alleles in a population and the number of cytotoxic T lymphocyte (CTL) escape mutations in epitopes restricted by those HLA alleles. Recently, it was demonstrated that at a population level HIV-1 is adapting to the humoral immune response, which is reflected in an increase in resistance to neutralizing antibodies over time. Here we investigated whether adaptations to cellular immunity have also accumulated during the epidemic. METHODS: We compared the number of CTL epitopes in HIV-1 strains isolated from individuals who seroconverted at the beginning of the HIV-1 epidemic and from individuals who seroconverted in recent calendar time. RESULTS: The number of CTL epitopes in HIV-1 variants restricted by the most common HLA alleles in the population did not change significantly during the epidemic. In contrast, we found a significant loss of CTL epitopes restricted by HLA-B alleles associated with a low relative hazard of HIV-1 disease progression during the epidemic. Such a loss was not observed for CTL epitopes restricted by HLA-A alleles. CONCLUSION: Despite the large degree of HLA polymorphism, HIV-1 has accumulated adaptations to CTL responses within 20 years of the epidemic. The fact that such adaptations are driven by the HLA-B molecules that provide best protection against HIV-1 disease progression has important implications for our understanding of HIV evolution.
Authors: Natalie N Kinloch; Daniel R MacMillan; Anh Q Le; Laura A Cotton; David R Bangsberg; Susan Buchbinder; Mary Carrington; Jonathan Fuchs; P Richard Harrigan; Beryl Koblin; Margot Kushel; Martin Markowitz; Kenneth Mayer; M J Milloy; Martin T Schechter; Theresa Wagner; Bruce D Walker; Jonathan M Carlson; Art F Y Poon; Zabrina L Brumme Journal: J Virol Date: 2015-11-11 Impact factor: 5.103
Authors: Will Fischer; Cristian Apetrei; Mario L Santiago; Yingying Li; Rajeev Gautam; Ivona Pandrea; George M Shaw; Beatrice H Hahn; Norman L Letvin; Gary J Nabel; Bette T Korber Journal: J Virol Date: 2012-10-10 Impact factor: 5.103
Authors: Mopo Radebe; Kamini Gounder; Mammekwa Mokgoro; Zaza M Ndhlovu; Zenele Mncube; Lungile Mkhize; Mary van der Stok; Manjeetha Jaggernath; Bruce D Walker; Thumbi Ndung'u Journal: AIDS Date: 2015-01-02 Impact factor: 4.177
Authors: Christian L Boutwell; Jonathan M Carlson; Tien-Ho Lin; Aaron Seese; Karen A Power; Jian Peng; Yanhua Tang; Zabrina L Brumme; David Heckerman; Arne Schneidewind; Todd M Allen Journal: J Virol Date: 2013-01-30 Impact factor: 5.103
Authors: Rebecca Payne; Maximilian Muenchhoff; Jaclyn Mann; Hannah E Roberts; Philippa Matthews; Emily Adland; Allison Hempenstall; Kuan-Hsiang Huang; Mark Brockman; Zabrina Brumme; Marc Sinclair; Toshiyuki Miura; John Frater; Myron Essex; Roger Shapiro; Bruce D Walker; Thumbi Ndung'u; Angela R McLean; Jonathan M Carlson; Philip J R Goulder Journal: Proc Natl Acad Sci U S A Date: 2014-12-01 Impact factor: 11.205
Authors: Laura A Cotton; Xiaomei T Kuang; Anh Q Le; Jonathan M Carlson; Benjamin Chan; Denis R Chopera; Chanson J Brumme; Tristan J Markle; Eric Martin; Aniqa Shahid; Gursev Anmole; Philip Mwimanzi; Pauline Nassab; Kali A Penney; Manal A Rahman; M-J Milloy; Martin T Schechter; Martin Markowitz; Mary Carrington; Bruce D Walker; Theresa Wagner; Susan Buchbinder; Jonathan Fuchs; Beryl Koblin; Kenneth H Mayer; P Richard Harrigan; Mark A Brockman; Art F Y Poon; Zabrina L Brumme Journal: PLoS Genet Date: 2014-04-24 Impact factor: 5.917
Authors: Luuk Gras; Ronald B Geskus; Suzanne Jurriaans; Margreet Bakker; Ard van Sighem; Daniela Bezemer; Christophe Fraser; Jan M Prins; Ben Berkhout; Frank de Wolf Journal: PLoS One Date: 2013-05-27 Impact factor: 3.240